MedTrace Logo

Clinical Trials

NCT01522976 | ACTIVE_NOT_RECRUITING | PHASE2
282 participants

Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2012-03-01
Completion:
2015-06-01
Conditions
  • Chronic Myelomonocytic Leukemia
  • Chronic Myelomonocytic Leukemia-1
  • Chronic Myelomonocytic Leukemia-2
  • Myelodysplastic Syndrome
  • Myelodysplastic Syndrome With Excess Blasts
  • Myelodysplastic Syndrome With Excess Blasts-1
  • Myelodysplastic Syndrome/Acute Myeloid Leukemia
Interventions
  • DRUG
  • OTHER
Results Available
NCT01366144 | ACTIVE_NOT_RECRUITING | PHASE1
94 participants

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2011-06-20
Completion:
2017-11-10
Conditions
  • Breast Carcinoma
  • Carcinoma of Unknown Primary
  • Endometrial Carcinoma
  • Esophageal Carcinoma
  • Liver Failure
  • Lung Carcinoma
  • Malignant Head and Neck Neoplasm
  • Malignant Testicular Neoplasm
  • Melanoma
  • Metastatic Malignant Solid Neoplasm
  • Ovarian Carcinoma
  • Renal Failure
  • Unresectable Malignant Neoplasm
  • Urothelial Carcinoma
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT01142388 | ACTIVE_NOT_RECRUITING | PHASE2
94 participants

Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2010-09-21
Completion:
2014-07-15
Conditions
  • Metastatic Esophageal Adenocarcinoma
  • Metastatic Esophageal Squamous Cell Carcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Recurrent Esophageal Adenocarcinoma
  • Recurrent Esophageal Carcinoma
  • Recurrent Esophageal Squamous Cell Carcinoma
  • Recurrent Gastroesophageal Junction Adenocarcinoma
  • Stage IV Esophageal Cancer AJCC v7
Interventions
  • BIOLOGICAL
  • OTHER
  • DRUG
Results Available
NCT01134614 | ACTIVE_NOT_RECRUITING | PHASE2
245 participants

Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2010-12-28
Completion:
2013-02-15
Conditions
  • Advanced Melanoma
  • Metastatic Melanoma
  • Recurrent Melanoma
  • Stage III Cutaneous Melanoma AJCC v7
  • Stage IIIA Cutaneous Melanoma AJCC v7
  • Stage IIIB Cutaneous Melanoma AJCC v7
  • Stage IIIC Cutaneous Melanoma AJCC v7
  • Stage IV Cutaneous Melanoma AJCC v6 and v7
  • Unresectable Melanoma
Interventions
  • BIOLOGICAL
Results Available
NCT01012817 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
88 participants

Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2009-11-03
Completion:
2019-01-13
Conditions
  • Metastatic Malignant Solid Neoplasm
  • Recurrent Fallopian Tube Carcinoma
  • Recurrent Ovarian Carcinoma
  • Recurrent Primary Peritoneal Carcinoma
  • Unresectable Solid Neoplasm
Interventions
  • OTHER
  • DRUG
Results Available
NCT00977574 | ACTIVE_NOT_RECRUITING | PHASE2
349 participants

Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2009-09-14
Completion:
2015-01-31
Conditions
  • Endometrial Adenocarcinoma
  • Endometrial Adenosquamous Carcinoma
  • Endometrial Clear Cell Adenocarcinoma
  • Endometrial Serous Adenocarcinoma
  • Recurrent Malignant Uterine Corpus Neoplasm
  • Stage IIIA Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage
  • Stage IIIB Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage
  • Stage IIIC Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage
  • Stage IVA Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage
  • Stage IVB Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v7 Stage
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
Results Available
NCT00310180 | ACTIVE_NOT_RECRUITING | PHASE3
10273 participants

Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-31
Start Date:
2006-04-07
Completion:
2018-03-02
Conditions
  • Breast Adenocarcinoma
  • Hormone Receptor Positive
  • Stage IA Breast Cancer AJCC v7
  • Stage IB Breast Cancer AJCC v7
  • Stage IIA Breast Cancer AJCC v6 and v7
  • Stage IIB Breast Cancer AJCC v6 and v7
  • Stage IIIB Breast Cancer AJCC v7
Interventions
  • DRUG
  • OTHER
  • RADIATION
Results Available
NCT07737782 | NOT_YET_RECRUITING
100 participants

Retrospective Cohort Study of Symptoms and Quality of Life in Women With Genitourinary Syndrome of Menopause.

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-30
Start Date:
2026-07-31
Completion:
2026-09-30
Conditions
  • Vulvar Atrophy
  • Vulvovaginal Signs and Symptoms
  • Genitourinary Syndrome of Menopause (GSM)
  • Quality of Life
  • Menopause Related Conditions
  • Dyspareunia
  • Urinary Incontinence, Urgency-frequency
  • Sexual Function
  • Women´s Health
  • Vaginal Dryness
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page